NEW YORK — Impiricus today announced that Vishwa Patel, Executive Vice President of People Operations, has been named to the 2025 MM+M Women to Watch list, an annual recognition celebrating healthcare marketing leaders who are shaping the future of the industry.
Now in its tenth year, MM+M’s Women of Distinction and Women to Watch programs honor executives who have delivered significant impact across their organizations and the broader healthcare ecosystem. Vishwa is recognized alongside women leaders from organizations including Genentech, Eli Lilly, UCB, Stealth BioTherapeutics, and Arcutis Biotherapeutics, representing a new generation of leaders advancing innovation across healthcare and life sciences.
At Impiricus, Vishwa architects the company’s human capital strategy at a defining moment of growth. The company was recently ranked the #1 fastest-growing company in North America on the 2025 Deloitte Technology Fast 500, reflecting rapid expansion and increasing demand for new approaches to physician engagement.
Under Vishwa’s leadership, Impiricus has built a modern People function from the ground up. She has operationalized talent acquisition, implemented measurable performance frameworks, and embedded inclusive hiring practices across the organization. Her work has helped shape a high-performance culture designed for scale while maintaining a strong commitment to psychological safety, diversity of perspective, and mission-driven impact.
That culture has earned external recognition as well. Impiricus was recently named one of Fortune’s Best Workplaces in Healthcare, a reflection of the environment Vishwa has helped build while the company has grown more than 30,000% over the past several years.
“Medical marketing stands out as an industry where women are leading the charge,” said Lecia Bushak, editor of pharma at MM+M. “For the 10th year in a row, we’ve been highlighting the extraordinary work of women who are driving creativity and innovation in the industry, as well as shaping the future of healthcare.”
At Impiricus, that mission extends beyond company growth. The organization was founded by a practicing physician and a pharmaceutical executive to transform how life sciences companies support physicians. The company’s AI-powered HCP Engagement Engine connects healthcare professionals to clinically meaningful resources in real time, accelerating access to life-saving treatments while reducing go-to-market inefficiencies across the industry. Vishwa’s leadership plays a critical role in ensuring the company can scale that mission with the right talent, culture, and organizational infrastructure.
About Impiricus
Impiricus is the first and only AI-powered HCP Engagement Engine. Recognized by Deloitte as the #1 fastest-growing company in North America on the 2025 Fast 500 list, Impiricus was founded by a practicing physician and a senior pharmaceutical executive to transform how life sciences companies support physicians.
With the largest opted-in network of healthcare professionals and a council of more than 2,000 physician advisors, Impiricus ethically connects providers to pharma resources, reduces go-to-market costs, and accelerates treatment access.
